News

Four early-phase studies being presented today during the 61st ASH Annual Meeting and Exposition spotlight the rapid advances being made in cellular immunotherapy for blood cancers.
Read more on American Society of Hematology »
Three studies being presented today during the ASH Annual Meeting and Exposition in Orlando help advance the treatment of adult and pediatric patients at risk of developing venous thromboembolism.
Read more on American Society of Hematology »
Five studies being presented today during the ASH Annual Meeting and Exposition in Orlando paint a mixed portrait of how demographics and socioeconomic status affect access to clinical trials and effective treatments for patients with blood cancers.
Read more on American Society of Hematology »
The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) announced today a collaboration to expand access to LLS’s unique free service providing clinical trials navigation and support to blood cancer patients and their families.
Read more on American Society of Hematology »
The American Society of Hematology (ASH) today released the most comprehensive set of recommendations to date aimed at establishing uniformity and global standards for clinical trial endpoints used to evaluate new therapies for sickle cell disease (SCD).
Read more on American Society of Hematology »
A new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiveness against human cancer cells grown in the laboratory and in mice, according to a new study.
Read more on Science Daily »
The ASH Research Collaborative has collaborated with two industry leaders, Novartis and Amgen, to include de-identified patient data from three separate studies of nearly 500 patients living with SCD and more than 1,000 patients with multiple myeloma as part of…
Read more on American Society of Hematology »
Today, ASH published new state-of-the art guidelines on the treatment of immune thrombocytopenia (ITP), a rare blood disorder characterized by a decrease in the number of platelets, the part of the blood needed for normal clotting. The guidelines are published…
Read more on American Society of Hematology »
The American Society of Hematology will recognize three Choosing Wisely® Champions, practitioners working to tackle overuse of hematology tests and treatments, at its 61st ASH Annual Meeting in Orlando.
Read more on American Society of Hematology »
Acute lymphoblastic leukemia is the most common form of cancer affecting children in Switzerland and, unfortunately, is often incurable. Researchers have now found a way to stop the driving force behind this type of leukemia at a molecular level and…
Read more on Science Daily »
While exercise offers benefits for a wide range of health conditions, it has historically been considered too dangerous for people living with sickle cell disease (SCD). However, a new study published today in the journal Blood adds to mounting evidence…
Read more on American Society of Hematology »
Older adults with blood cancers can benefit from a team-based, holistic evaluation before undergoing transplantation, according to a new study published today in Blood Advances. The study, which reported on a multidisciplinary clinic (MDC) at the University of Chicago Medical…
Read more on American Society of Hematology »
Researchers compare a lymphoma-dose regimen of rituximab to a rheumatoid arthritis regimen for the treatment of pemphigus.
Read more on Science Daily »
Leukemia stem cells initiate and sustain leukemia, but researchers have found a way to steer them toward a path of self-destruction.
Read more on Science Daily »
ASH is pleased to recognize the following trainees, who’s meritorious scientific abstract has received one of the awards in the ASH Abstract Achievement Award program portfolio, at the 61st ASH Annual Meeting, December 7-10 in Orlando.
Read more on American Society of Hematology »
An international collaboration has identified therapy-induced, drug-resistance mutations in children with acute lymphoblastic leukemia who relapse.
Read more on Science Daily »
Bioscientists find a way to predict the sensitivity of acute myeloid leukemia to mitochondria-damaging molecules and develop cocktails to fight the cancer. The discoveries could improve personalized cancer treatment.
Read more on Science Daily »
A survey of U.S. hematology-oncology fellows suggests medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly when students are exposed to hematology and oncology as part of core clerkships in internal medicine and…
Read more on American Society of Hematology »
The American Society of Hematology today announced the election of three new members to its Executive Committee for terms beginning after the 2019 ASH Annual Meeting, December 7-10 in Orlando.
Read more on American Society of Hematology »
The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.
Read more on Science Daily »